Should You Buy Defensive Stocks British American Tobacco plc, GlaxoSmithKline plc & Centrica PLC?

Will Defensive Stocks British American Tobacco plc (LON:BATS), GlaxoSmithKline plc (LON:GSK) & Centrica PLC (LON:CNA) Outperform In 2016?

| More on:

The content of this article was relevant at the time of publishing. Circumstances change continuously and caution should therefore be exercised when relying upon any content contained within this article.

You’re reading a free article with opinions that may differ from The Motley Fool’s Premium Investing Services. Become a Motley Fool member today to get instant access to our top analyst recommendations, in-depth research, investing resources, and more. Learn More.

World markets remain unstable despite the recent rally in equities . Investors looking to park capital in stocks that should perform ok in a prolonged bear market should be researching defensive plays. Historically defensive stocks have been in the consumer, utilities and healthcare sectors. The three stocks below are perfect defensive stocks that should hold up well in a downturn. 

Tobacco king

British American Tobacco (LSE: BATS) has been an outstanding performer since the year 2000, the share price has increased by a whopping 629% and the company has returned billions to shareholders in the form of dividends. The company manages to maintain margins of 30-36% and generate over £4bn in net profit each year.

Shareholders will see a substantial amount of this profit returned in a dividend of 154p a share (3.9%) which is covered 1.6 times by cash. The company is relatively cheap too — currently shares are trading on a P/E ratio of just over 17. This is lower than London’s other large tobacco stock Imperial Brands (LSE: IMB). 

British American Tobacco is a great stock to own in times like these because of the defensive nature of tobacco companies and the huge profit the company has consistently delivered for years. 

Pharma giant

GlaxoSmithKline (LSE: GSK) is an extremely popular defensive stock in the US and UK. The company operates in the healthcare sector and is expected to have revenues of over £25bn this year. Glaxo pays out a punchy 6% dividend and the shares still only trade on a P/E of 15, which is firmly in the bottom half of  its peer group.

The strong defensive qualities can be seen when looking at a 10 year chart for the stock — impressively the stock rose in during the 2008/2009 global financial crisis. This would suggest that if the world economy enters another recession then Glaxo shares would be a great place to have invested. 

The company has developed an exciting range of new drugs and treatments to help fill the revenue gap left by old treatments coming off patents. Although revenue is declining the company is keeping profits relatively steady, and the stock is definitely one to own in a downturn.  

UK utility

Utility stocks such as Centrica (LSE: CNE) are not something I would usually look at. However, in the current economic climate the sector may well outperform others by the end of the year. The headline attraction to Centrica is the 5.3% dividend yield but there could be a good turnaround story here.

After two years of losses the company is forecast to swing into a profit for 2016 and 2017 which could cause the shares to re-rate. The forecast P/E ratio for 2016 is 12.5 which is a good deal lower than its listed peers and that is something that I would expect to change. Centric has defensive qualities like the other stocks mentioned here but there is also considerable scope for capital growth. 

Centrica is reporting this week so that may give us some confirmation of the companies change in fortunes and the outlook going forward. 

Jack Dingwall has no position in any shares mentioned. The Motley Fool UK has recommended Centrica and GlaxoSmithKline. We Fools don't all hold the same opinions, but we all believe that considering a diverse range of insights makes us better investors.

More on Investing Articles

Night Takeoff Of The American Space Shuttle
Growth Shares

How UK investors can get access to the $2trn SpaceX stock IPO TODAY

Investors in the UK can get exposure to space powerhouse SpaceX today via several investment trusts that trade on the…

Read more »

Young black colleagues high-fiving each other at work
Investing Articles

Down 23% from its highs, I’ve just bagged myself a FTSE 100 bargain!

Stephen Wright has seized the opportunity to buy shares in a FTSE 100 company with outstanding growth prospects at an…

Read more »

Close-up image depicting a woman in her 70s taking British bank notes from her colourful leather wallet.
Investing Articles

How to turn an empty ISA into £100 a month in passive income

Stephen Wright outlines how real estate investment trusts can help UK investors aim for £100 a month in passive income…

Read more »

Man riding the bus alone
Investing Articles

Down 23%! Should I buy Meta Platforms for my ISA or SIPP?

Meta stock looks undervalued after sliding steadily lower since last summer. But should I buy the social media giant for…

Read more »

A rear view of a female in a bright yellow coat walking along the historic street known as The Shambles in York, UK which is a popular tourist destination in this Yorkshire city.
Investing Articles

£5,000 invested in Greggs shares 2 years ago is now worth…

Anyone who bought Greggs' shares two years ago will now be sitting on heavy losses. Is there potential for a…

Read more »

Investing Articles

10 days to the next stock market crash?

What happens to the stock market when the current ceasefire in the Middle East expires? And what should investors do…

Read more »

Middle-aged Caucasian woman deep in thought while looking out of the window
Investing Articles

How to try and double the State Pension with just £30 a week

By saving money each week and investing regularly, even someone without a lot of cash to spare can aim to…

Read more »

UK financial background: share prices and stock graph overlaid on an image of the Union Jack
Investing Articles

2 badly beaten-down small caps to consider for a £20,000 Stocks and Shares ISA

Ben McPoland highlights a pair of UK small caps that have sold off heavily, making them worth considering for a…

Read more »